Related Experiment Video
Updated: Feb 3, 2026

Purification of the Sarco-Endoplasmic Reticulum Ca2+-ATPase from Rabbit Muscle
Published on: March 21, 2025
Programmed Cell Death 5 Provides Negative Feedback on Cardiac Hypertrophy Through the Stabilization of
Jingjing Ye1, Qiaoxia Zheng2, Shi Jia1
1From the Department of Physiology and Pathophysiology, School of Basic Medical Sciences (J.Y., S.J., X.Q., Y.C., C.X., L.W., L.Z., M.Z.), Peking University Health Science Center, Beijing, China.
Abstract:
PDCD5 (programmed cell death 5) is ubiquitously expressed in tissues, including the heart; however, the mechanism underlying the cardiac function of PDCD5 has not been understood. We investigated the mechanisms of PDCD5 in the pathogenesis of cardiac hypertrophy. Cardiac-specific PDCD5 knockout mice developed severe cardiac hypertrophy and impaired cardiac function, whereas PDCD5 protein was significantly increased in transverse aortic constriction mouse hearts and phenylephrine-stimulated cardiomyocytes. Overexpression of PDCD5 inhibited phenylephrine-induced cardiomyocyte hypertrophy, and knockdown of PDCD5 induced cardiomyocyte hypertrophy and aggravated phenylephrine-induced hypertrophy. The expression of PDCD5 protein was regulated by NFATc2 (nuclear factor of activated T cells c2) during hypertrophy. SERCA2a (sarco/endoplasmic reticulum Ca2+-ATPase 2a) expression was decreased in PDCD5-deficient mouse hearts because of increased ubiquitination. PDCD5-deficient cardiomyocytes displayed decreased calcium uptake rate, slowed decay of Ca2+ transients, decreased calcium stores, and diastolic dysfunction. Moreover, reintroduction of PDCD5 in PDCD5-deficient mouse hearts reserved SERCA2a protein, suppressed NFATc2 protein, and rescued the hypertrophy and cardiac dysfunction. Our results revealed that PDCD5 is a novel target of NFATc2 in the hypertrophic heart and provides negative feedback to protect the heart against excessive hypertrophy via the stabilization of SERCA2a protein.
Insights
Programmed cell death 5 (PDCD5) protects the heart against hypertrophy by stabilizing SERCA2a protein. PDCD5 acts as a negative feedback mechanism, preventing excessive cardiac growth and dysfunction.
Area of Science:
- Cardiology
- Molecular Biology
- Cellular Physiology
Background:
- Programmed cell death 5 (PDCD5) is widely expressed, but its role in cardiac function remains unclear.
- Cardiac hypertrophy is a significant risk factor for heart failure.
Purpose of the Study:
- To elucidate the role of PDCD5 in the pathogenesis of cardiac hypertrophy.
- To investigate the molecular mechanisms by which PDCD5 influences cardiac function.
Main Methods:
- Utilized cardiac-specific PDCD5 knockout mice and cardiomyocyte models.
- Analyzed protein expression, ubiquitination, and calcium handling.
- Investigated the regulatory relationship between PDCD5, NFATc2, and SERCA2a.
Main Results:
- PDCD5 deficiency led to severe cardiac hypertrophy, impaired function, and reduced SERCA2a levels.
- PDCD5 protein levels increased in hypertrophic hearts and were regulated by NFATc2.
- PDCD5 overexpression inhibited hypertrophy, while knockdown exacerbated it.
- PDCD5 stabilized SERCA2a by preventing its ubiquitination, improving calcium handling and cardiac function.
Conclusions:
- PDCD5 is a novel NFATc2 target in hypertrophic hearts.
- PDCD5 acts as a protective factor against cardiac hypertrophy through SERCA2a stabilization.
- PDCD5 represents a potential therapeutic target for treating cardiac hypertrophy.
Related Concept Videos
Endoplasmic Reticulum
The Endoplasmic Reticulum
Directing Proteins to the Rough Endoplasmic Reticulum
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Positive and Negative Feedback Loops
Feedback Inhibition

